Skip to main navigation Skip to search Skip to main content

Integrative pathway enrichment analysis of multivariate omics data

  • PCAWG Drivers and Functional Interpretation Working Group
  • , PCAWG Consortium
  • Ontario Institute for Cancer Research
  • University of Toronto
  • University of California at Los Angeles
  • Wellcome Trust Genome Campus
  • Baylor College of Medicine
  • Jackson Laboratory
  • University of Texas MD Anderson Cancer Center
  • Broad Institute
  • Dana-Farber Cancer Institute
  • Harvard University
  • Aarhus University
  • RIKEN
  • Technical University of Denmark
  • University of Copenhagen
  • Cambridge University Hospitals NHS Foundation Trust
  • University of Cambridge
  • University of Bern
  • German Cancer Research Center
  • Heidelberg University 
  • Korea Advanced Institute of Science and Technology
  • Institute for Research in Biomedicine
  • Pompeu Fabra University
  • Cornell University
  • Uppsala University
  • Barcelona Supercomputing Center (BSC)
  • University of Queensland
  • European Molecular Biology Laboratory
  • University of Porto
  • University of Milan - Bicocca
  • Peter Maccallum Cancer Centre
  • University of Melbourne
  • Princeton University
  • Yale University
  • Massachusetts General Hospital
  • Hospital del Mar
  • Barcelona Institute of Science and Technology (BIST)
  • University of California Santa Cruz
  • Stanford University
  • University of Texas Health Science Center at Houston
  • Simon Fraser University

Research output: Contribution to journalArticlepeer-review

172 Citations (Scopus)

Abstract

Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high-dimensional molecular profiles pose challenges to data interpretation and hypothesis generation. ActivePathways is an integrative method that discovers significantly enriched pathways across multiple datasets using statistical data fusion, rationalizes contributing evidence and highlights associated genes. As part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2658 cancers across 38 tumor types, we integrated genes with coding and non-coding mutations and revealed frequently mutated pathways and additional cancer genes with infrequent mutations. We also analyzed prognostic molecular pathways by integrating genomic and transcriptomic features of 1780 breast cancers and highlighted associations with immune response and anti-apoptotic signaling. Integration of ChIP-seq and RNA-seq data for master regulators of the Hippo pathway across normal human tissues identified processes of tissue regeneration and stem cell regulation. ActivePathways is a versatile method that improves systems-level understanding of cellular organization in health and disease through integration of multiple molecular datasets and pathway annotations.

Original languageEnglish
Article number735
JournalNature Communications
Volume11
Issue number1
DOIs
Publication statusPublished - 1 Dec 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Integrative pathway enrichment analysis of multivariate omics data'. Together they form a unique fingerprint.

Cite this